| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/18/2007 | CA2614597A1 Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors |
| 01/18/2007 | CA2614147A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 01/18/2007 | CA2614000A1 Novel 1h-indole-pyridinecarboxamide and 1h-indole- piperidinecarboxamine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/18/2007 | CA2613985A1 N-thio-anthranilamid compounds and their use as pesticides |
| 01/18/2007 | CA2612765A1 Antidiabetic oxazolidinediones and thiazolidinediones |
| 01/18/2007 | CA2612442A1 Heterotetracyclic compounds as tpo mimetics |
| 01/18/2007 | CA2602389A1 Kinase inhibitors |
| 01/17/2007 | EP1743893A1 Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol |
| 01/17/2007 | EP1743892A1 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 01/17/2007 | EP1743888A1 Carbonyl substituted pyrazoline compounds, their preparation and use as CB1 receptor modulators |
| 01/17/2007 | EP1743887A1 Thiocarbonyl-substituted pyrazoline compounds, their preparation and use as CB1 modulators |
| 01/17/2007 | EP1743885A2 TNF-Alpha Produktion Hemmer zur Behandlung von Autoimmunerkrankungen |
| 01/17/2007 | EP1742940A1 N-[6-(4-morpholinyl)-3-pyridinyl]-2-(tetrahydro-2h-pyran-4-yl)-n-[(1-{[phenyl]methyl}-4-piperidinyl)methyl] acetamide derivatives and related compounds as glyt1 transport inhibitors for the treatment of neurological disorders such as schizophrenia |
| 01/17/2007 | EP1742936A2 Polycyclic pyridines as potassium ion channel modulators |
| 01/17/2007 | EP1742935A1 Polycyclic pyrazines as potassium ion channel modulators |
| 01/17/2007 | EP1742934A2 Piperidine derivatives as modulators of chemokine receptor ccr5 |
| 01/17/2007 | EP1742933A2 Crystalline methanesulfonic acid addition salts of imatinib |
| 01/17/2007 | EP1742932A1 3-heterocyclyl-4-phenyl-triazole derivatives as inhibitors of the vasopressin v1a receptor |
| 01/17/2007 | EP1742918A1 Lxr receptor modulators |
| 01/17/2007 | EP1742913A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 01/17/2007 | EP1742912A1 Novel androgens |
| 01/17/2007 | EP1742911A1 3,4-disubstituted maleimides for use as vascular damaging agents |
| 01/17/2007 | EP1742909A2 Anionic-sweetener-based ionic liquids and methods of use thereof |
| 01/17/2007 | EP1742707A2 Treatment of cns disorders using cns target modulators |
| 01/17/2007 | EP1742634A1 Polycyclic pyrimidines as potassium ion channel modulators |
| 01/17/2007 | EP1742631A1 Fluorinated 4-azasteroids as androgen receptor modulators |
| 01/17/2007 | EP1480970B1 Quinoline derivatives |
| 01/17/2007 | EP1400518B1 Heterocyclic compound derivatives and medicines |
| 01/17/2007 | EP1392309B1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/17/2007 | EP1383751B1 Novel azoles having an insecticidal action |
| 01/17/2007 | EP1345900B1 Guanidine and amidine derivatives as factor xa inhibitors |
| 01/17/2007 | EP1268444B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
| 01/17/2007 | CN1898244A Triazole derivatives as vasopressin antagonists |
| 01/17/2007 | CN1898235A Heterocyclic derivatives as gpcr receptor agonists |
| 01/17/2007 | CN1898234A Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 01/17/2007 | CN1898231A Bipiperidinyl derivatives useful as inhibitors of chemokine receptors |
| 01/17/2007 | CN1898216A Amide derivatives |
| 01/17/2007 | CN1898214A Dicationic triaryl analogs as anti-protozoan agents |
| 01/17/2007 | CN1898210A 2-pyridinylethylcarboxamide derivatives and their use as fungicides |
| 01/17/2007 | CN1898208A Amide derivative and medicine |
| 01/17/2007 | CN1898206A Allosteric modulators of metabotropic glutamate receptors |
| 01/17/2007 | CN1898205A Indolinone derivatives and their use in treating disease-states such as cancer |
| 01/17/2007 | CN1898204A 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
| 01/17/2007 | CN1898199A Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/17/2007 | CN1897952A Neutrophilia inhibitor |
| 01/17/2007 | CN1897948A Alkoxy substituted imidazoquinolines |
| 01/17/2007 | CN1897944A Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 01/17/2007 | CN1896074A Fluorescent molecular probe and use for inspecting transient metal and heavy metal ion |
| 01/17/2007 | CN1896073A New phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/17/2007 | CN1896070A 2- and 2,5-substituted phenylketo-enols |
| 01/17/2007 | CN1896066A Preparation of Insecticide |
| 01/17/2007 | CN1896060A Tetrahydro-indolone and tetrahydro-indazolone derivatives and their use |
| 01/17/2007 | CN1295228C Nitryl methylene derivatives and uses thereof |
| 01/17/2007 | CN1295227C Barbituric acid derivs with antimetastatic and antitumor activity |
| 01/17/2007 | CN1295221C Substituted heterocyclic compounds |
| 01/17/2007 | CN1295219C Red light emitting naphthyl imide compound and its synthetic method |
| 01/17/2007 | CN1295216C Molindone derivatives and use for preparing antineoplastic medicine thereof |
| 01/16/2007 | US7164027 Aralkyl ester soft drugs |
| 01/16/2007 | US7164024 Muscarinic acetylcholine receptor antagonist; Parkinson's disease; dystonia; analgesics; irritable bowel syndrome |
| 01/16/2007 | US7164023 Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate |
| 01/16/2007 | US7163990 Polymerization catalyst |
| 01/16/2007 | US7163952 Azole compound and medicinal use thereof |
| 01/16/2007 | US7163951 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 01/16/2007 | US7163943 e.g., 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3 ,5]triazine-2,4-diamine; inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells and inhibit smooth muscle proliferation. |
| 01/16/2007 | US7163940 Pyrazolopyridinyl pyrimidine therapeutic compounds |
| 01/16/2007 | US7163938 Substituted carboxamides |
| 01/16/2007 | US7163937 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/16/2007 | CA2219742C N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 01/11/2007 | WO2007005972A1 Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds |
| 01/11/2007 | WO2007005951A2 Stereoisomeric pyridyl and pyridonyl compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| 01/11/2007 | WO2007005673A1 Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors |
| 01/11/2007 | WO2007005668A2 Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer |
| 01/11/2007 | WO2007005503A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 01/11/2007 | WO2007005404A1 AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION |
| 01/11/2007 | WO2007005366A1 AMlNO-5-(5-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR β-SECRETASE MODULATION |
| 01/11/2007 | WO2007004959A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson's disease |
| 01/11/2007 | WO2007004543A1 Pharmaceutical composition comprising 2-pyridone derivative as active ingredient |
| 01/11/2007 | WO2007003965A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 01/11/2007 | WO2007003964A1 G-protein coupled receptor agonists |
| 01/11/2007 | WO2007003962A2 Gpcr agonists |
| 01/11/2007 | WO2007003960A1 Gpcr agonists |
| 01/11/2007 | WO2007003934A2 17beta-hydr0xyster0id dehydrogenase type 3 (17beta-hsd3 ) inhibitors |
| 01/11/2007 | WO2007003604A2 Hists1mine h3 receptor antagonists |
| 01/11/2007 | WO2007003271A1 Salt of embusartan |
| 01/11/2007 | WO2006113498A3 2-amino-quinaz0lin-5-ones as hsp90 inhibitors useful in treating proliferation diseases |
| 01/11/2007 | WO2006094209A3 N-benzimidazolylalkyl-substituted amide sirtuin modulators |
| 01/11/2007 | WO2006020959A3 Substituted benzofused heterocycles |
| 01/11/2007 | WO2006014359A3 Compounds useful for inhibiting chk1 |
| 01/11/2007 | WO2006009734A8 Gonadotropin releasing hormone receptor antagonists |
| 01/11/2007 | WO2006008194A9 3-pyridinylethylcarboxamide derivatives as fungicides |
| 01/11/2007 | US20070010673 Purification means |
| 01/11/2007 | US20070010569 4-Methyl-5-(2-oxo-1,2-dihydroindol-3- ylidenemethyl)-1H-pyrrole-2- carboxylic acid; cancer |
| 01/11/2007 | US20070010561 Prenylation inhibitors and methods of their synthesis and use |
| 01/11/2007 | US20070010560 Benzimidazole derivatives as raf kinase inhibitors |
| 01/11/2007 | US20070010558 Opioid receptor antagonists |
| 01/11/2007 | US20070010557 Novel amides useful for treating pain |
| 01/11/2007 | US20070010551 Quinoline derivatives as neutrophil elastase inhibitors and their use |
| 01/11/2007 | US20070010534 Novel compounds |
| 01/11/2007 | US20070010532 3-Pyridylcarboxamide derivatives as pesticidal agents |
| 01/11/2007 | US20070010531 Substituted pyrazole compounds |